The TGF-β pathway: a pharmacological target in hepatocellular carcinoma?

Hepat Oncol. 2017 Apr;4(2):35-38. doi: 10.2217/hep-2017-0012. Epub 2017 Jul 6.

Authors

Isabel Fabregat^{1

1}, Gianluigi Giannelli^{2

2}; IT-LIVER Consortium

Affiliations

¹ Bellvitge Biomedical Research Institute (IDIBELL) & University of Barcelona, L'Hospitalet, Barcelona, Spain.
² National Institute of Gastroenterology IRCCS 'S. De Bellis', Castellana Grotte Bari, Italy.

No abstract available

Keywords: HCC; TGF-beta; targeted therapy.

Publication types

Editorial